Lanean...
External quality assessment for laboratory testing of HLA‐B*15:02 allele in relation to carbamazepine therapy
BACKGROUND: Due to the significant risk of developing Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), the use of carbamazepine is not recommended in patients carrying the human leukocyte antigen B (HLA‐B) *15:02 allele. In an effort to guarantee reliable community‐based HLA‐B*15...
Gorde:
| Argitaratua izan da: | J Clin Lab Anal |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6817111/ https://ncbi.nlm.nih.gov/pubmed/28440597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.22242 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|